Researchers working with mice now need to find way to detect proteins indicating disease in humans; finding could lead to 'significant delay' in progression of debilitating disease

New drug stalls progression of disease for patients who have the BRCA genetic mutations, study by Sheba Medical Center with AstraZeneca and Merck shows